Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelis, Biogen, Bridgebio, Brii, Cardiol, Chemomab, Eli Lilly, Esperion, Genethon, GSK, Immunitybio, Incyte, Merck, Newamsterdam, Nicox, Ocugen, Pliant, Protagonist, Regenxbio, Rocket, Silence, Thermosome, Vir.